EDC/NHS chemistry was used to graft functional groups (alanine and GSH), couple therapeutic molecules (ibuprofen and dopamine) on PLG backbone and label the co-polypeptides with R6G (Fig
Phase 1 trial evaluating TTI-101, a first-in-class, orally bioavailable, small molecule, inhibitor of STAT3, in patients with advanced solid tumors
Brain Res (1983) 264(2):24153
Studies on MTHFR variants show no interactions with vaccinations, with the exception of a smallpox vaccine that is not regularly given
Possible Side Effects Mild injection site reaction (transient) Rare: temporary skin discoloration at injection site Very low systemic side effect profile No hormonal effects Important: GHK-Cu has an extensive safety record across decades of research in cosmetic and medical applications
Links Contacts Thibault Cavali Laboratoire d'Astrophysique de Bordeaux Bordeaux, France Tel: +33 (0)5 40 00 32 71 Email: [email protected] Bilal Benmahi Laboratoire d'Astrophysique de Bordeaux Bordeaux, France Tel: +33 (0)5 40 00 32 76 Email: [email protected] Vincent Hue Southwest Research Institute San Antonio, TX, USA Tel: +1 (210) 522-5027 Email: [email protected] Thomas Greathouse Southwest Research Institute San Antonio, TX, USA Tel: +1 (210) 522-2809 Email: [email protected] Suzanna Randall (astronomer who did not participate in the study
